NKGen (NKGN): Market Capitalization
NKGen Biotech, Inc. (NKGN) focuses on independently conducting clinical trials against Alzheimer's disease while leveraging academic partners for funding. The company is implementing AI bioreactors to automate cell cultivation and reduce manual labor costs. This daily price chart for the company on GURU.Markets reflects a level of 0.01. The business is also expanding its profile by developing NK-cell-based therapies for cancer and neurodegeneration.
NKGN (NKGen Biotech Corp): analytical breakdowns and indicator data
- market price and analyst price targets:
- stock exchange capitalization data:
- issuer book value statistics:
- debt and liquidity details:
Total Debt to Capital NKGen Biotech, Inc.|NKGN - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio NKGen Biotech, Inc.|NKGN - Company Aggregate Debts|Debt to Book Capitalization Ratio NKGen Biotech Corp|NKGN - Company Long-Term Loans and Borrowings|Company Short-Term Debt NKGen Biotech|Quick Liquidity nkgenbiotech.com
- business earnings and investment ratios data:
NKGN - Company Profit|Expected Profit NKGen Biotech, Inc.|NKGN - P/E Multiple|Forward P/E Multiple NKGen|NKGN - Price to Net Income Growth Ratio|EV/EBITDA Multiple NKGen Biotech Corp|NKGN - Profit before interest, taxes and amortization|Earnings per share for the last twelve months NKGen Biotech|NKGN - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months nkgenbiotech.com|NKGN - Earnings per share increase in current year|Earnings growth forecast for next year NKGen Biotech, Inc.
Fundamental company analysis:NKGN (NKGen Biotech)
The resilience of NKGen Biotech, Inc. (NKGN) depends on the stability of global supply chains and patent protection. These factors directly impact the market value of all shares, determined by the product of the current price and the number of securities. This metric reflects the real-time assessment of the business by investors. Sharp fluctuations in the company's market capitalization signal high volatility. Peak values on the chart often precede deep corrections.
Key competitors
Market Value Biogen BIIB|Market Capitalization Neurocrine NBIX|Regencell - Market Capitalization|Market Capitalization Axsome Corp (AXSM)|ACADIA Pharmaceuticals (ACAD) - Market Value|Market Capitalization XENE|Market Value Viking Therapeutics, Inc.|Market Capitalization SUPN (Supernus Pharmaceuticals, Inc.)|Market Capitalization CPRX|DNLI - Market Value|Harmony Biosciences - Market Valuation|Market Capitalization biohavenpharma.com BHVN|AMLX - Market Value|Market Value TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Market Value|Market Value Anavex Life Sciences Corp (AVXL)|Market Value CeriBell, Inc.|Market Capitalization PRTA (Prothena Corp)|Market Value Alector, Inc. (ALEC)|Market Capitalization Annexon Biosciences (ANNX)|Market Capitalization OMER (Omeros)|Market Capitalization Neurogene Therapeutics|AC Immune - Market Capitalization|Market Value voyagertherapeutics.com|Neumora Therapeutics, Inc. (NMRA) - Market Value|Market Capitalization SCLX|Market Valuation TVGN|ACOG: Market Value|Market Capitalization CGTX|Market Value IKT (inhibikase.com)|Market Capitalization SAVA (Cassava Sciences)|Market Capitalization Assertio Holdings (ASRT)|COYA - Market Value|Market Value Vistagen Therapeutics|OVID (ovidrx.com) - Market Valuation|ABOS: Market Value|CRVO (CervoMed) - Market Capitalization|Market Value Alterity Therapeutics Ltd ATHE|Market Capitalization CLNN|Market Valuation pepgen.com PEPG|Market Capitalization JUNS (Jupiter Neurosciences)|Market Value RLMD|ANVS: Market Valuation|Market Value GRCE (Grace Therapeutics, Inc.)|AIFF: Market Capitalization|KLTO - Market Capitalization|Market Value NeuroSense Therapeutics Ltd|Market Capitalization RVPH (revivapharma.com)|Market Capitalization MTVA|Market Valuation NeurAxis Inc. NRXS|Helius Medical Technologies - Market Valuation|Market Capitalization Passage Bio Inc. (PASG)|NEUP - Market Value|NERV (minervaneurosciences.com) - Market Capitalization|Athira Pharma (ATHA) - Market Value|Addex Therapeutics Ltd. (ADXN) - Market Capitalization|ALZN (Alzamend Neuro Inc.) - Market Capitalization|CYCN - Market Capitalization|Market Value Protagenic Therapeutics (PTIX)|pasitheaclinics.com - Market Capitalization|Market Value Cortigent CRGT|ATXI: Market Capitalization|Brainstorm Cell Therapeutics, Inc. - Market Capitalization|Market Value Cara Therapeutics Inc|CHRO (Chromocell Therapeutics) - Market Valuation|Eliem Therapeutics Inc. (ELYM) - Market Capitalization|Market Value Intra-Cellular Therapies Inc.|LBPH: Market Value|Market Value Marinus (MRNS)|NRBO - Market Value|Market Value Sage Therapeutics, Inc. SAGE|SNPX: Market Capitalization|TRVN - Market Value|VIGL - Market Capitalization|WENA: Market Capitalization|Market Capitalization Cerevel Corp CERE
